Related Experiment Video
Updated: May 6, 2026
Generation of CAR T Cells for Adoptive Therapy in the Context of Glioblastoma Standard of Care
Published on: February 16, 2015
Mapping clinical CAR-T cells: insights from scRNA-seq
Michaela M Meehl1, Meghan B Ward2, Giedre Krenciute2
1Department of Bone Marrow Transplantation and Cellular Therapy (BMTCT), St. Jude Children's Research Hospital, Memphis, TN, USA; College of Graduate Health Sciences, University of Tennessee Health Science Center, Memphis, TN, USA.
Single cell RNA sequencing (scRNA-seq) offers deep insights into chimeric antigen receptor (CAR)-T cell therapy by analyzing T cell exhaustion, cytotoxicity, and memory. This review summarizes scRNA-seq applications in CAR-T cell research, highlighting patient response and future directions.
Area of Science:
- Immunology
- Genomics
- Biotechnology
Background:
- Single cell RNA sequencing (scRNA-seq) is a powerful tool for analyzing cellular transcriptional profiles.
- It is increasingly applied in various biological disciplines, including chimeric antigen receptor (CAR)-T cell therapy.
Purpose of the Study:
- To comprehensively review published studies utilizing scRNA-seq to analyze clinical CAR-T cells.
- To focus on key aspects of CAR-T cell function and their relevance to patient outcomes.
Main Methods:
- Systematic review of published literature on scRNA-seq applications in CAR-T cell therapy.
- Analysis of findings related to T cell exhaustion, cytotoxicity, memory, expansion, clonal diversity, cytokines, activation, CD4+/CD8+ ratios, proliferation, regulatory T cells (Tregs), and metabolism.
Main Results:
- scRNA-seq provides critical data on CAR-T cell phenotypes, including exhaustion, cytotoxicity, and memory formation.
- Analysis reveals insights into T cell activation, proliferation, and metabolic profiles impacting patient response.
- Findings on CD4+/CD8+ ratios and regulatory T cells (Tregs) are relevant across various diseases.
Conclusions:
- scRNA-seq is instrumental in understanding CAR-T cell behavior and predicting patient response.
- The review highlights the utility of scRNA-seq in advancing CAR-T cell therapy research.
- Limitations and future research avenues for scRNA-seq in this field are discussed.
